Copyright Reports & Markets. All rights reserved.

Global Piroxicam Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Piroxicam Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Piroxicam Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Suppositories
    • 1.4.3 Injection
    • 1.4.4 Capsule
    • 1.4.5 Patch
    • 1.4.6 Other
  • 1.5 Market by Application
    • 1.5.1 Global Piroxicam Market Share by Application: 2020 VS 2026
    • 1.5.2 Tendonitis
    • 1.5.3 Systemic Traumatic Pain
    • 1.5.4 Musculoskeletal Pain
    • 1.5.5 Contraception
    • 1.5.6 Rheumatoid Arthritis
    • 1.5.7 Chronic Infectious Arthritis
    • 1.5.8 Osteoarthritis
    • 1.5.9 Other
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Piroxicam Market Perspective (2015-2026)
  • 2.2 Piroxicam Growth Trends by Regions
    • 2.2.1 Piroxicam Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Piroxicam Historic Market Share by Regions (2015-2020)
    • 2.2.3 Piroxicam Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Piroxicam Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Piroxicam Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Piroxicam Players by Market Size
    • 3.1.1 Global Top Piroxicam Players by Revenue (2015-2020)
    • 3.1.2 Global Piroxicam Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Piroxicam Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Piroxicam Market Concentration Ratio
    • 3.2.1 Global Piroxicam Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Piroxicam Revenue in 2019
  • 3.3 Piroxicam Key Players Head office and Area Served
  • 3.4 Key Players Piroxicam Product Solution and Service
  • 3.5 Date of Enter into Piroxicam Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Piroxicam Historic Market Size by Type (2015-2020)
  • 4.2 Global Piroxicam Forecasted Market Size by Type (2021-2026)

5 Piroxicam Breakdown Data by Application (2015-2026)

  • 5.1 Global Piroxicam Market Size by Application (2015-2020)
  • 5.2 Global Piroxicam Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Piroxicam Market Size (2015-2020)
  • 6.2 Piroxicam Key Players in North America (2019-2020)
  • 6.3 North America Piroxicam Market Size by Type (2015-2020)
  • 6.4 North America Piroxicam Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Piroxicam Market Size (2015-2020)
  • 7.2 Piroxicam Key Players in Europe (2019-2020)
  • 7.3 Europe Piroxicam Market Size by Type (2015-2020)
  • 7.4 Europe Piroxicam Market Size by Application (2015-2020)

8 China

  • 8.1 China Piroxicam Market Size (2015-2020)
  • 8.2 Piroxicam Key Players in China (2019-2020)
  • 8.3 China Piroxicam Market Size by Type (2015-2020)
  • 8.4 China Piroxicam Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Piroxicam Market Size (2015-2020)
  • 9.2 Piroxicam Key Players in Japan (2019-2020)
  • 9.3 Japan Piroxicam Market Size by Type (2015-2020)
  • 9.4 Japan Piroxicam Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Piroxicam Market Size (2015-2020)
  • 10.2 Piroxicam Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Piroxicam Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Piroxicam Market Size by Application (2015-2020)

11 India

  • 11.1 India Piroxicam Market Size (2015-2020)
  • 11.2 Piroxicam Key Players in India (2019-2020)
  • 11.3 India Piroxicam Market Size by Type (2015-2020)
  • 11.4 India Piroxicam Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Piroxicam Market Size (2015-2020)
  • 12.2 Piroxicam Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Piroxicam Market Size by Type (2015-2020)
  • 12.4 Central & South America Piroxicam Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Pfizer
    • 13.1.1 Pfizer Company Details
    • 13.1.2 Pfizer Business Overview and Its Total Revenue
    • 13.1.3 Pfizer Piroxicam Introduction
    • 13.1.4 Pfizer Revenue in Piroxicam Business (2015-2020))
    • 13.1.5 Pfizer Recent Development
  • 13.2 Teva
    • 13.2.1 Teva Company Details
    • 13.2.2 Teva Business Overview and Its Total Revenue
    • 13.2.3 Teva Piroxicam Introduction
    • 13.2.4 Teva Revenue in Piroxicam Business (2015-2020)
    • 13.2.5 Teva Recent Development
  • 13.3 Mylan
    • 13.3.1 Mylan Company Details
    • 13.3.2 Mylan Business Overview and Its Total Revenue
    • 13.3.3 Mylan Piroxicam Introduction
    • 13.3.4 Mylan Revenue in Piroxicam Business (2015-2020)
    • 13.3.5 Mylan Recent Development
  • 13.4 Nostrum
    • 13.4.1 Nostrum Company Details
    • 13.4.2 Nostrum Business Overview and Its Total Revenue
    • 13.4.3 Nostrum Piroxicam Introduction
    • 13.4.4 Nostrum Revenue in Piroxicam Business (2015-2020)
    • 13.4.5 Nostrum Recent Development
  • 13.5 DCPC
    • 13.5.1 DCPC Company Details
    • 13.5.2 DCPC Business Overview and Its Total Revenue
    • 13.5.3 DCPC Piroxicam Introduction
    • 13.5.4 DCPC Revenue in Piroxicam Business (2015-2020)
    • 13.5.5 DCPC Recent Development
  • 13.6 FANGMING
    • 13.6.1 FANGMING Company Details
    • 13.6.2 FANGMING Business Overview and Its Total Revenue
    • 13.6.3 FANGMING Piroxicam Introduction
    • 13.6.4 FANGMING Revenue in Piroxicam Business (2015-2020)
    • 13.6.5 FANGMING Recent Development
  • 13.7 JINGHUA
    • 13.7.1 JINGHUA Company Details
    • 13.7.2 JINGHUA Business Overview and Its Total Revenue
    • 13.7.3 JINGHUA Piroxicam Introduction
    • 13.7.4 JINGHUA Revenue in Piroxicam Business (2015-2020)
    • 13.7.5 JINGHUA Recent Development
  • 13.8 JUMPCAN
    • 13.8.1 JUMPCAN Company Details
    • 13.8.2 JUMPCAN Business Overview and Its Total Revenue
    • 13.8.3 JUMPCAN Piroxicam Introduction
    • 13.8.4 JUMPCAN Revenue in Piroxicam Business (2015-2020)
    • 13.8.5 JUMPCAN Recent Development
  • 13.9 Technilab Pharma
    • 13.9.1 Technilab Pharma Company Details
    • 13.9.2 Technilab Pharma Business Overview and Its Total Revenue
    • 13.9.3 Technilab Pharma Piroxicam Introduction
    • 13.9.4 Technilab Pharma Revenue in Piroxicam Business (2015-2020)
    • 13.9.5 Technilab Pharma Recent Development
  • 13.10 Apotex Corporation
    • 13.10.1 Apotex Corporation Company Details
    • 13.10.2 Apotex Corporation Business Overview and Its Total Revenue
    • 13.10.3 Apotex Corporation Piroxicam Introduction
    • 13.10.4 Apotex Corporation Revenue in Piroxicam Business (2015-2020)
    • 13.10.5 Apotex Corporation Recent Development
  • 13.11 Keltman Pharmaceuticals
    • 10.11.1 Keltman Pharmaceuticals Company Details
    • 10.11.2 Keltman Pharmaceuticals Business Overview and Its Total Revenue
    • 10.11.3 Keltman Pharmaceuticals Piroxicam Introduction
    • 10.11.4 Keltman Pharmaceuticals Revenue in Piroxicam Business (2015-2020)
    • 10.11.5 Keltman Pharmaceuticals Recent Development
  • 13.12 Genpharm
    • 10.12.1 Genpharm Company Details
    • 10.12.2 Genpharm Business Overview and Its Total Revenue
    • 10.12.3 Genpharm Piroxicam Introduction
    • 10.12.4 Genpharm Revenue in Piroxicam Business (2015-2020)
    • 10.12.5 Genpharm Recent Development
  • 13.13 Bayer
    • 10.13.1 Bayer Company Details
    • 10.13.2 Bayer Business Overview and Its Total Revenue
    • 10.13.3 Bayer Piroxicam Introduction
    • 10.13.4 Bayer Revenue in Piroxicam Business (2015-2020)
    • 10.13.5 Bayer Recent Development
  • 13.14 PLX Pharma
    • 10.14.1 PLX Pharma Company Details
    • 10.14.2 PLX Pharma Business Overview and Its Total Revenue
    • 10.14.3 PLX Pharma Piroxicam Introduction
    • 10.14.4 PLX Pharma Revenue in Piroxicam Business (2015-2020)
    • 10.14.5 PLX Pharma Recent Development
  • 13.15 Chiesi
    • 10.15.1 Chiesi Company Details
    • 10.15.2 Chiesi Business Overview and Its Total Revenue
    • 10.15.3 Chiesi Piroxicam Introduction
    • 10.15.4 Chiesi Revenue in Piroxicam Business (2015-2020)
    • 10.15.5 Chiesi Recent Development
  • 13.16 SK Chemicals
    • 10.16.1 SK Chemicals Company Details
    • 10.16.2 SK Chemicals Business Overview and Its Total Revenue
    • 10.16.3 SK Chemicals Piroxicam Introduction
    • 10.16.4 SK Chemicals Revenue in Piroxicam Business (2015-2020)
    • 10.16.5 SK Chemicals Recent Development
  • 13.17 Bioglan Laboratories
    • 10.17.1 Bioglan Laboratories Company Details
    • 10.17.2 Bioglan Laboratories Business Overview and Its Total Revenue
    • 10.17.3 Bioglan Laboratories Piroxicam Introduction
    • 10.17.4 Bioglan Laboratories Revenue in Piroxicam Business (2015-2020)
    • 10.17.5 Bioglan Laboratories Recent Development
  • 13.18 APR
    • 10.18.1 APR Company Details
    • 10.18.2 APR Business Overview and Its Total Revenue
    • 10.18.3 APR Piroxicam Introduction
    • 10.18.4 APR Revenue in Piroxicam Business (2015-2020)
    • 10.18.5 APR Recent Development
  • 13.19 CJ HealthCare
    • 10.19.1 CJ HealthCare Company Details
    • 10.19.2 CJ HealthCare Business Overview and Its Total Revenue
    • 10.19.3 CJ HealthCare Piroxicam Introduction
    • 10.19.4 CJ HealthCare Revenue in Piroxicam Business (2015-2020)
    • 10.19.5 CJ HealthCare Recent Development
  • 13.20 SkyePharma
    • 10.20.1 SkyePharma Company Details
    • 10.20.2 SkyePharma Business Overview and Its Total Revenue
    • 10.20.3 SkyePharma Piroxicam Introduction
    • 10.20.4 SkyePharma Revenue in Piroxicam Business (2015-2020)
    • 10.20.5 SkyePharma Recent Development
  • 13.21 Changzhou Siyao Pharmaceutical
    • 10.21.1 Changzhou Siyao Pharmaceutical Company Details
    • 10.21.2 Changzhou Siyao Pharmaceutical Business Overview and Its Total Revenue
    • 10.21.3 Changzhou Siyao Pharmaceutical Piroxicam Introduction
    • 10.21.4 Changzhou Siyao Pharmaceutical Revenue in Piroxicam Business (2015-2020)
    • 10.21.5 Changzhou Siyao Pharmaceutical Recent Development
  • 13.22 Shanxi Yunpeng Pharmaceutical
    • 10.22.1 Shanxi Yunpeng Pharmaceutical Company Details
    • 10.22.2 Shanxi Yunpeng Pharmaceutical Business Overview and Its Total Revenue
    • 10.22.3 Shanxi Yunpeng Pharmaceutical Piroxicam Introduction
    • 10.22.4 Shanxi Yunpeng Pharmaceutical Revenue in Piroxicam Business (2015-2020)
    • 10.22.5 Shanxi Yunpeng Pharmaceutical Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    This report focuses on the global Piroxicam status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Piroxicam development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

    The key players covered in this study
    Pfizer
    Teva
    Mylan
    Nostrum
    DCPC
    FANGMING
    JINGHUA
    JUMPCAN
    Technilab Pharma
    Apotex Corporation
    Keltman Pharmaceuticals
    Genpharm
    Bayer
    PLX Pharma
    Chiesi
    SK Chemicals
    Bioglan Laboratories
    APR
    CJ HealthCare
    SkyePharma
    Changzhou Siyao Pharmaceutical
    Shanxi Yunpeng Pharmaceutical

    Market segment by Type, the product can be split into
    by Dosage Form
    Suppositories
    Injection
    Capsule
    Patch
    Other
    by Route
    Oral
    Rectal
    Market segment by Application, split into
    Tendonitis
    Systemic Traumatic Pain
    Musculoskeletal Pain
    Contraception
    Rheumatoid Arthritis
    Chronic Infectious Arthritis
    Osteoarthritis
    Other

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global Piroxicam status, future forecast, growth opportunity, key market and key players.
    To present the Piroxicam development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

    In this study, the years considered to estimate the market size of Piroxicam are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
    For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

    Buy now